NIKKEI FT Communicable Diseases Conference

Hideaki ANAN, MD, PhD, FJSIM

Chairperson,

Kanagawa Prefectural Hospital Organization

Mr. Kiyoshi ANDO

Senior Staff Writer, Nikkei Inc.

Iringó DEMETER, M.Sc.,M.Sc.,

Member Management Team, INCATE – Incubator for Antibacterial Therapies

Dr. Yohei DOI

Professor

Departments of Microbiology and Infectious Diseases, Fujita Health University School of Medicine

Dr. Stanley KAMAU HSC

Executive Founder/CEO , Ahadi Kenya Trust

Mr. Yann FERRISSE

Director, Business Development & Partner Engagement

Global Antibiotic R&D Partnership (GARDP)

Daisuke FUJIWARA Ph., D.

Executive Office, Director of Institute of Health Sciences, Kirin Holdings Company, Limited

Yuki FURUSE, MD, PhD

Professor; The University of Tokyo Pandemic Preparedness, Infection and Advanced Research Center

Dr Tedros Adhanom GHEBREYESUS

Director-General

World Health Organization

M.D.,Ph.D Michinari HAMAGUCHI

Director General, Strategic Center of Biomedical Advanced Vaccine Research and Development for Preparedness and Response(SCARDA), Japan Agency for Medical Research and Development (AMED)

Mr. Ryousuke HARADA

Senior fellow of Editorial boad

Nikkei Inc.

Dr. Minako HIJIKATA, MD, PhD

Department Head, Department of Pathophysiology and Host Defense

The Research Institute of Tuberculosis, JATA

Eiji HINOSHITA, MD, PhD, MSc

Cabinet Councilor

Cabinet Agency for Infectious Disease Crisis Management (CAICM), Cabinet Secretariat

Shoji HIRASHIMA, Ph.D.

Daiichi Sankyo Co., Ltd.

Representative Director, Senior Executive Officer, Head of Japan Business Unit

Prof. Kenji HIRAYAMA, MD. Ph.D.

Professor / School of Tropical Medicine and Global Health, Nagasaki University

Mr. Yoshihide HIRUTA

General Manager, External Relations on International Cooperation, Business Strategy Development

Sysmex Corporation

Mr. Mamoru ICHIKAWA

Healthcare Evangelist

Mr. Masayuki IMAGAWA, M.B.A., M.Sc., R.Ph.

Head, Vaccine Business Unit

Takeda Pharmaceutical Co., Ltd.

Ken J. ISHII, M.D., Ph.D.

Professor,

Division of Vaccine Science, Department of Microbiology and Immunology

The Institute of Medical Science, The University of Tokyo

Prof. Yasuhiko KAMIYA, MD, MTroPaed, PhD

Professor

School of Tropical Medicine and Global Health Nagasaki University

Dr. Seiya KATO

Director,

Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association (RIT/ JATA)

Prof. KITA Kiyoshi

Dean and Professor,

School of Tropical Medicine and Global Health,

Nagasaki University

The University of Tokyo, Professor Emeritus

Dr. KITA Yosuke

Director, Global Health Strategy Division, Ministry of Foreign Affairs, Government of Japan

Mr. Daikichiro KOBAYASHI

President and Representative Director

Meiji Seika Pharma Co., Ltd.

Mr. Michikazu KOSHIBA

Director, Advisory Services Division,

Government & Public Sector – Healthcare / Well-being, KPMG AZSA LLC

Dr. Osamu KUNII, MD, MPH, PhD,

CEO and Executive Director at the GHIT Fund

Yutaka KOGUCHI, PhD

Mitsubishi Tanabe Pharma Corporation

General Manager, Head of Discovery Technology Laboratories Research Division

Mr. Shinichiro KOMOTO

Partner,

Eight Roads Ventures Japan

Dr. Akihisa MAEDA

Director, Vaccination Division, Ministry of Health, Labour, and Welfare

Hideki MAKI, PhD

Principal Scientist, Laboratory for Drug Discovery and Disease Research, Shionogi & Co., Ltd.

Prof. Dr. Izuru MAKIHARA

Professor

Research Center for Advanced Science and Technology, University of Tokyo

Prof. Tetsuya MATSUMOTO, MD, PhD

Department of Infectious Diseases

Chief Professor, International University of Health and Welfare

Prof. Shuzo MATSUSHITA, MD, PhD

Professor; Joint Research Center

for Human Retrovirus Infection, Division of Clinical Retrovirology, Kumamoto University

Prof. Noboru MINAKAWA Ph.D.

Institute of Tropical Medicine, Nagasaki University

Professor

Dr. Hiroaki MITSUYA , MD, PhD

Director; Research Institute

National Center for Global Health and Medicine

Mr. Mitsuru MIYATA

CEO

Miyata Institute of Technologies,K.K.

Mr. Toshiaki MURAMOTO

Managing Director

General Manager, International Division

Fumakilla Limited

Prof. Kaori MUTO, PhD

Professor,

Department of Public Policy, Human Genome Center, The Institute of Medical Science, The University of Tokyo

Mr. Toshiaki NAGASATO

President and Representative Director

KM Biologics Co.,Ltd

Prof. Dr. Kazutoshi NAKASHIMA, MD, PhD

Professor

Department of Health Science, Faculty of Sports and Health Science,

Daito Bunka University

Ms. Kaori NAKATANI

Director of Office, DNDi Japan

Ho NAMKOONG MD, PhD, MPH

Assistant Professor, Department of Infectious Diseases, Keio University School of Medicine

Prof. Yumiko NARA, PhD

Professor,

Graduate School of Human Life and Health Sciences Program,

The Open University of Japan

Tomoyo NARITA, MD, MPH, PhD

Deputy Director General for Technical Affairs,

Bureau of Public Health, Tokyo Metropolitan Government

Mr. Takeshi NARUSE

KM Biologics Co., Ltd.

Senior Managing Executive Officer, Senior Manager, R&D Division

Ms Aurélia NGUYEN

Deputy CEO, CEPI

Prof. Dr. Ryosuke NISHIDA

Professor, College of Risk Management, Nihon University

Specially Appointed Professor, Institute for Liberal Arts Tokyo Institute of Technology

Prof. Shuhei NOMURA, PhD

Professor,

Keio University Global Research Institute

Mr. Ryoji NORITAKE

Chair

Health and Global Policy Institute (HGPI)

Mr.Dennis NTARA

General Manager , Saraya Kenya Co., Ltd

Prof. Kazumasa OGURO

Professor

Hosei University

Prof. Fumio OHTAKE

Specially Appointed Professor

Center for Infectious Disease Education and Research (CiDER), Osaka University

Dr. Shigeru OMI, MD, PhD

Japan Anti-Tuberculosis Association, Chairman, Representative,Board of Director

World Health Organization (WHO), Regional Office for Western Pacific

Masayuki OMOTE, PhD

Executive Director, Clinical Development Japan, Gilead Sciences KK

Mr. Michael PEEL

Science Editor

Financial Times

Dr. David REDDY

Director General, IFPMA

Associate Prof. Aya SAITOH, RN, PHN, PhD

Department of Fundamental Nursing, Graduate School of Health Sciences, Niigata University

Ms. Marie-Ange SARAKA-YAO

Chief Resource Mobilisation & Growth Officer

Gavi, the Vaccine Alliance

Dr. Masahiro SASAKI

Senior Assistant Minister for Health Security and Technology, Ministry of Health, Labour and Welfare

PhD. Tomonori SASAKI

Fumakilla LIMITED / Research & Development division /

Fundamental Science research department / Department manager

Ms. Takuko SAWADA

Director and Vice Chairperson of the Board,

Shionogi & Co., Ltd.

Kengo SONODA, PhD

Executive Officer, Senior Manager, CMC Development Division

KM Biologics Co.,Ltd

Prof. Nahoko SHINDO, MD, PhD

Senior Advisor,

WHO Health Emergencies Programme (WHE),

World Health Organization

Dr. Kenji SHUTO

Vice Governor

Kanagawa Prefecture

Manabu SUMI, MD, MPH, PhD

Director-General

Department of Infectious Disease Prevention and Control

Ministry of Health, Labour and Welfare

Dr. Yosuke SUNAHARA

Kobe University

Graduate School of Law

H.E. Mr. Hideo SUZUKI

Ambassador for Global Health

Dr. Chika TAKAHASHI MD/PhD

Infectious diseases control division/Manager : Setagaya Public Health Center

Mr. Keizo TAKEMI

Former Minister of Health, Labour and Welfare

Member, the House of Councillors

Prof. Kayo TAKUMA

Professor, Faculty of Law, Keio University

Mikihito TANAKA, Ph.D.

Professor, Faculty of Political Science and Economics, Waseda University

Dr. Junko TANUMA, MD, PhD

Professor, Department of Infectious Diseases, School of Medicine

Professor, Department of Global Health and Infectious Diseases, Graduate School of Public Health

International University of Health and Welfare

Mr. Toru TANZAWA

Head of Vaccine Business Division

Vaccine Business Division Japane Business Unit Daiichi Sankyo Co., Ltd.

Dr. Kazuhiro TATEDA, MD, PhD

Professor

Department of Microbiology and Infectious Diseases /

Toho University School of Medicine

Mr. Koji TAWARA

Director, Medical Education Division, Higher Education Bureau, Ministry of Education, Culture, Sports, Science and Technology

Isao TESHIROGI, Ph.D.

Chief Executive Officer

Shionogi & Co., Ltd.

Dr. Amit N. THAKKER

Executive Chairman

Africa Health Business

Hiroaki UENO, Ph.D.

Japan Pharmaceutical Manufacturers Association

President

Hayato URABE, PhD, MPIA

Associate Vice President, Investment Strategy, Portfolio Development & Innovations

Global Health Innovative Technology Fund (GHIT Fund)

Dr. Takaji WAKITA, M.D.,Ph.D.

DIRECTOR GENERAL

NATIONAL INSTITUTE OF INFECTIOUS DISEASES